These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 38069160)
1. Molecular Mechanism of Alzheimer's Disease. Rammes G Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069160 [TBL] [Abstract][Full Text] [Related]
2. Epigenetics and DNA methylomic profiling in Alzheimer's disease and other neurodegenerative diseases. Roubroeks JAY; Smith RG; van den Hove DLA; Lunnon K J Neurochem; 2017 Oct; 143(2):158-170. PubMed ID: 28805248 [TBL] [Abstract][Full Text] [Related]
3. Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy. Latta CH; Brothers HM; Wilcock DM Neuroscience; 2015 Aug; 302():103-11. PubMed ID: 25286385 [TBL] [Abstract][Full Text] [Related]
6. Molecular biology of the amyloid of Alzheimer's disease. An overview. Inestrosa NC; Soto C Biol Res; 1992; 25(2):63-72. PubMed ID: 1365703 [TBL] [Abstract][Full Text] [Related]
7. The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders. Carmona S; Zahs K; Wu E; Dakin K; Bras J; Guerreiro R Lancet Neurol; 2018 Aug; 17(8):721-730. PubMed ID: 30033062 [TBL] [Abstract][Full Text] [Related]
9. Role of Notch signaling in neurovascular aging and Alzheimer's disease. Kapoor A; Nation DA Semin Cell Dev Biol; 2021 Aug; 116():90-97. PubMed ID: 33384205 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of neuropathological changes in Alzheimer's disease: a review. Serý O; Povová J; Míšek I; Pešák L; Janout V Folia Neuropathol; 2013; 51(1):1-9. PubMed ID: 23553131 [TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease. Cacabelos R Mol Diagn Ther; 2007; 11(6):385-405. PubMed ID: 18078356 [TBL] [Abstract][Full Text] [Related]
12. Abnormal interaction of Rlip with mutant APP/Abeta and phosphorylated tau reduces wild-type Rlip levels and disrupt Rlip function in Alzheimer's disease. Baig J; Sawant N; Rawat P; Reddy AP; Reddy PH; Kshirsagar S Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166858. PubMed ID: 37633469 [TBL] [Abstract][Full Text] [Related]
13. Molecular genetics of Alzheimer's disease: the role of beta-amyloid and the presenilins. Tandon A; Rogaeva E; Mullan M; St George-Hyslop PH Curr Opin Neurol; 2000 Aug; 13(4):377-84. PubMed ID: 10970053 [TBL] [Abstract][Full Text] [Related]
16. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Maccioni RB; Muñoz JP; Barbeito L Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751 [TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of Alzheimer's disease and the amyloid beta peptide precursor gene. Tanzi RE Ann Med; 1989; 21(2):91-4. PubMed ID: 2504259 [TBL] [Abstract][Full Text] [Related]
18. The genetics of Alzheimer's disease. Kennedy AM; Brown J; Rossor M Baillieres Clin Neurol; 1994 Aug; 3(2):217-40. PubMed ID: 7952845 [TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in the pathophysiology of Alzheimer's disease and Parkinson's disease: an overview. Khezri MR; Yousefi K; Zolbanin NM; Ghasemnejad-Berenji M Mol Neurobiol; 2022 Mar; 59(3):1589-1603. PubMed ID: 35001356 [TBL] [Abstract][Full Text] [Related]
20. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases. Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]